Allergy Testing Access Act of 2019
Official title: A bill to amend titles XVIII and XIX of the Social Security Act to provide equal coverage of in vitro specific IgE tests and percutaneous tests for allergies u… Show full official titleShow less
Official title: A bill to amend titles XVIII and XIX of the Social Security Act to provide equal coverage of in vitro specific IgE tests and percutaneous tests for allergies under the Medicare and Medicaid programs, and for other purposes.
More subjectsShow fewer subjects
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Read twice and referred to the Committee on Finance.
Allergy Testing Access Act of 2019
This bill requires equal coverage of two types of allergy tests under Medicaid and Medicare.
Specifically, in vitro specific IgE tests (blood tests) and percutaneous tests (skin tests) must be treated equally with respect to (1) medical necessity or other coverage requirements, (2) frequency limits, and (3) allergen unit limits.
- Introduced in Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). S. 2246: Allergy Testing Access Act of 2019. 116th Congress. Open America. https://openamerica.io/bill/116-S-2246/
"S. 2246: Allergy Testing Access Act of 2019." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-S-2246/.
S. 2246, 116th Cong. (2026), https://openamerica.io/bill/116-S-2246/.
[S. 2246: Allergy Testing Access Act of 2019](https://openamerica.io/bill/116-S-2246/)